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Background: Noncompaction cardiomyopathy (NCC) is a rare genetic cardiomyopathy characterized by a thin,
compacted epicardial layer and an extensive noncompacted endocardial layer. The clinical manifestations of this
disease include ventricular arrhythmia, heart failure, and systemic thromboembolism.
Case presentation: A 43-year-old male was anticoagulated by pulmonary thromboembolism for 1 year when
he developed progressive dyspnea. Cardiovascular magnetic resonance imaging showed severe biventricular
trabeculation with an ejection fraction of 15%, ratio of maximum noncompacted/compacted diastolic myocardial
thickness of 3.2 and the presence of exuberant biventricular apical thrombus.
Conclusion: Still under discussion is the issue of which patients and when they should be anticoagulated. It is
generally recommended to those presenting ventricular systolic dysfunction, antecedent of systemic embolism,
presence of cardiac thrombus and atrial fibrillation. In clinical practice the patients with NCC and ventricular
dysfunction have been given oral anticoagulation, although there are no clinical trials showing the real safety and
benefit of this treatment.
Keywords: Cardiomyopathy, Echocardiography, Magnetic resonance, Noncompaction, ThromboembolismBackground
According to the American Heart Association, non-
compaction cardiomyopathy (NCC) is a genetic dis-
order [1] characterized by intrauterine arrest of the
process of myocardial compaction that starts at the
8th week of gestation. Clinical manifestations include
ventricular arrhythmia, heart failure, and systemic
thromboembolism, especially encephalic. Ventricular
hypertrabeculation is believed to be an anatomical
substrate for the formation of thrombi. The literature
shows an important variation in the incidence of em-
bolic events in NCC between 0% and 38%, with few
references to pulmonary thromboembolism [2]. Yousef
et al. found it in 7% of patients [3]. The main limita-
tion of these findings is the small number of patients
in the studies.* Correspondence: marcelo_dtm@yahoo.com.br
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A 43-year-old male, obese, former-smoker patient was
suffering from gout and had been anticoagulated
by pulmonary thromboembolism for 1 year when
he developed progressive dyspnea without anginal
complaints. He was directed to a tertiary hospital for
investigation of heart failure. Through echocardio-
graphic evaluation, severe biventricular diffuse systolic
dysfunction with suspicion of noncompacted cardio-
myopathy was identified, even though such a hypoth-
esis could not be confirmed [Figure 1]. Cardiovascular
magnetic resonance imaging (CMRI) showed severe
biventricular trabeculation with an ejection fraction of
15%, ratio of maximum noncompacted/compacted
diastolic myocardial thickness of 3.2 and the presence
of exuberant biventricular apical thrombus [Figure 2,
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Figure 1 Echocardiographic images showing severe left ventricular systolic dysfunction (A) and a grade 2 diastolic dysfunction pattern
(B to D).
Tavares de Melo et al. BMC Cardiovascular Disorders 2015, 15:7 Page 2 of 4
http://www.biomedcentral.com/1471-2261/15/7gadolinium enhancement at 2/17 segments (mid-ante-
roseptal and apical septal). Coronary computed tomog-
raphy angiogram showed a calcified nonobstructive
plaque in the proximal left anterior descending coron-
ary artery [Figure 3].
In 2008, according to Fazio et al., NCC does not present
thromboembolic risk and there is no indication for anticoa-
gulation [4]. On the other hand, nowadays, the indication
for anticoagulation treatment in NCC is still debatable.
Almeida et al. recommended anticoagulation only in cases
of left ventricular dilation and dysfunction or with previous
embolic events [5]. Recently, Stöllberger and Finsterer
stated that thrombi may also develop in patients with NCC
even with preserved systolic function [6]. It is gener-
ally recommended to those presenting ventricular sys-
tolic dysfunction, antecedent of systemic embolism,
presence of cardiac thrombus and atrial fibrillation
[7]. CMRI plays a crucial role in the diagnosis of left
ventricular noncompaction, especially for its accuracy
in detecting ventricular thrombi. No prospective study
demonstrates the benefits of anticoagulation in NCCpatients, which generates uncertainty and insecurity,
because there are reports of patients without ventricu-
lar dysfunction or atrial fibrillation who have suffered
a systemic thromboembolism.Conclusion
This case report presents a patient with severe biventri-
cular dysfunction in sinus rhythm, with previous pul-
monary thromboembolism and biventricular thrombi.
He presents a formal indication for anticoagulation. On
the other hand, more studies are necessary to clarify
this approach for patients presenting NCC with ven-
tricular dysfunction in sinus rhythm.Consent
Written informed consent was obtained from the pa-
tient for publication of this Case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor of this journal.
Figure 2 Cardiovascular magnetic resonance short axis cine images showing left ventricular wall and trabeculation, with maximum
non-compacted to compacted thickness ratio of 3.2 (normal < 2.3) (A); delayed enhancement long-axis five-chamber view showing left
ventricular apical thrombus (B); multiple long-axis four-chambers disclosing biventricular thrombus (C); multiple short-axis two-chambers
illustrating the same biventricular thrombus (D). LV (left ventricle).
Figure 3 Coronary computed tomography angiogram showing
a calcified nonobstructive plaque in the proximal left anterior
descending coronary artery.
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Additional file 1: Four-chamber view cine steady state free precession
cardiac MRI. The left ventricle has increased diastolic volume and severe
ventricular dysfunction.Abbreviations
CMRI: Cardiovascular magnetic resonance imaging; NCC: Noncompaction
cardiomyopathy.
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